ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma launches generic drug with 180-day exclusivity in US
Natco Pharma has launched Bosentan tablets, a generic version of Tracleer, in the US for treating pulmonary arterial hypertension in young patients. This launch comes with 180-day exclusivity. Lupin Ltd. is Natco's marketing partner for this product. The d
Announcement as on 20 August 2025

Natco Pharma to buy over 35% in South Africa's Adcock Ingram
Natco Pharma, based in Hyderabad, is set to acquire a 35.75% stake in Adcock Ingram, South Africa's second-largest drugmaker, for ₹2,000 crore. This all-cash deal provides Natco Pharma with a strong entry into high-growth African markets and expands its
Announcement as on 24 July 2025

Natco Pharma offers to acquire nearly 36% stake in Adcock Ingram in Rs 2,100-cr deal
Natco Pharma has made a firm offer to acquire nearly 36% stake in South African drug firm Adcock Ingram Holdings for up to Rs 2,100 crore. This acquisition will provide Natco Pharma with a strong entry into the Southern African market and expand its footpr
Announcement as on 23 July 2025

Delhi HC asks Natco Pharma to pause Risdiplam launch amid patent dispute
The Delhi High Court has ordered Natco Pharma to maintain status quo on the launch of Risdiplam until April 2. Roche, which holds the patent for the drug, sought an injunction to prevent Natco from manufacturing it in India. The court highlighted the publi
Announcement as on 26 March 2025

Delhi HC rejects Roche's plea to block Natco Pharma on Risdiplam patent
The Delhi High Court denied Roche's request to temporarily restrain Natco Pharma from producing its spinal muscular atrophy drug, citing public interest and high prices. Natco is required to maintain detailed financial records and may owe damages if Roche
Announcement as on 24 March 2025

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 888.65
  • 12Day Average: 869.7
  • 20Day Average: 905.9
  • 50Day Average: 1041.9
  • 100Day Average: 989.56
  • 150Day Average: 955.03
  • 200Day Average: 924.77

524816 Indicators & signals

Indicator MACD (12,26,9)

893.86, 944.04, -57.83
Indicator MACD is in negative zone

Indicator ADX (14)

13.16, 20.64, 26.9
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 39
Indicator RSI is indicating selling pressure and stock might fall.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
24 Wed Jun 2026 893.95 890.00 to 913.35 0.11% 1.04 times
23 Tue Jun 2026 892.95 885.25 to 913.00 0.97% 2.01 times
22 Mon Jun 2026 884.35 881.80 to 892.75 -0.5% 0.22 times
19 Fri Jun 2026 888.75 877.00 to 909.00 0.62% 0.61 times
18 Thu Jun 2026 883.25 862.80 to 895.80 1.86% 1.67 times
17 Wed Jun 2026 867.10 844.05 to 869.00 1.83% 1.01 times
16 Tue Jun 2026 851.55 841.50 to 858.25 0.47% 0.34 times
15 Mon Jun 2026 847.55 839.80 to 888.95 -1.89% 1.19 times
12 Fri Jun 2026 863.85 849.75 to 866.00 2.53% 0.81 times
11 Thu Jun 2026 842.55 839.35 to 874.90 -1.46% 1.3 times
10 Wed Jun 2026 855.00 852.00 to 876.35 -1.22% 0.84 times
09 Tue Jun 2026 865.55 856.10 to 879.70 -0.35% 1.19 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top